journal article Dec 08, 2011

Quinpirole elicits differential in vivo changes in the pre- and postsynaptic distributions of dopamine D2 receptors in mouse striatum: relation to cannabinoid-1 (CB1) receptor targeting

View at Publisher Save 10.1007/s00213-011-2553-4
Topics

No keywords indexed for this article. Browse by subject →

References
77
[1]
Artigas F (2010) The prefrontal cortex: a target for antipsychotic drugs. Acta Psychiatr Scand 121:11–21 10.1111/j.1600-0447.2009.01455.x
[2]
The Role of the Dorsal Striatum in Reward and Decision-Making: Figure 1.

Bernard W. Balleine, Mauricio R. Delgado, Okihide Hikosaka

The Journal of Neuroscience 10.1523/jneurosci.1554-07.2007
[3]
Bamford NS, Zhang H, Schmitz Y, Wu NP, Cepeda C, Levine MS, Schmauss C, Zakharenko SS, Zablow L, Sulzer D (2004) Heterosynaptic dopamine neurotransmission selects sets of corticostriatal terminals. Neuron 42:653–663 10.1016/s0896-6273(04)00265-x
[4]
Belin D, Jonkman S, Dickinson A, Robbins TW, Everitt BJ (2009) Parallel and interactive learning processes within the basal ganglia: relevance for the understanding of addiction. Behav Brain Res 199:89-102 10.1016/j.bbr.2008.09.027
[5]
Bellocchio E, Hu H, Pohorille A, Chan J, Pickel V, Edwards R (1998) The localization of the brain-specific inorganic phosphate transporter suggests a specific presynaptic role in glutamatergic transmission. J Neurosci 18:8648–8659 10.1523/jneurosci.18-21-08648.1998
[6]
Dissociable Control of Impulsivity in Rats by Dopamine D2/3 Receptors in the Core and Shell Subregions of the Nucleus Accumbens

Morgane Besson, David Belin, Ruth McNamara et al.

Neuropsychopharmacology 2010 10.1038/npp.2009.162
[7]
Bortolato M, Aru G, Fa M, Frau R, Orru M, Salis P, Casti A, Luckey G, Mereu G, Gessa G (2005) Activation of D1, but not D2 receptors potentiates dizocilpine-mediated disruption of prepulse inhibition of the startle. Neuropsychopharmacology 30:561–574 10.1038/sj.npp.1300547
[8]
Bouaboula M, Bianchini L, McKenzie F, Pouyssegur J, Casellas P (1999) Cannabinoid receptor CB1 activates the Na+/H+ exchanger NHE-1 isoform via Gi-mediated mitogen activated protein kinase signaling transduction pathways. FEBS Lett 449:61–65 10.1016/s0014-5793(99)00395-6
[9]
Brana C, Aubert I, Charron G, Pellevoisin C, Bloch B (1997) Ontogeny of the striatal neurons expressing the D2 dopamine receptor in humans: an in situ hybridization and receptor-binding study. Mol Brain Res 48:389–400 10.1016/s0169-328x(97)00114-9
[10]
Chan J, Aoki C, Pickel V (1990) Optimization of differential immunogold-silver and peroxidase labeling with maintenance of ultrastructure in brain sections before plastic embedding. J Neurosci Methods 33:113–127 10.1016/0165-0270(90)90015-8
[11]
Charara A, Smith Y, Parent A (1996) Glutamatergic inputs from the pedunculopontine nucleus to midbrain dopaminergic neurons in primates: phaseolus vulgaris-leucoagglutinin anterograde labeling combined with postembedding glutamate and GABA immunohistochemistry. J Comp Neurol 364:254–266 10.1002/(sici)1096-9861(19960108)364:2<254::aid-cne5>3.0.co;2-4
[12]
Churchill L, Austin MC, Kalivas PW (1992) Dopamine and endogenous opioid regulation of picrotoxin-induced locomotion in the ventral pallidum after dopamine depletion in the nucleus accumbens. Psychopharmacology (Berl) 108:141–146 10.1007/bf02245299
[13]
Del Arco A, Mora F (2009) Neurotransmitters and prefrontal cortex-limbic system interactions: implications for plasticity and psychiatric disorders. J Neural Transm 116:941–952 10.1007/s00702-009-0243-8
[14]
Delle Donne KT, Sesack SR, Pickel VM (1997) Ultrastructural immunocytochemical localization of the dopamine D2 receptor within GABAergic neurons of the rat striatum. Brain Res 746:239–255 10.1016/s0006-8993(96)01226-7
[15]
Durstewitz D, Seamans J, Sejnowski T (2000) Dopamine-mediated stabilization of delay-period activity in a network model of prefrontal cortex. J Neurophysiol 83:1733–1750 10.1152/jn.2000.83.3.1733
[16]
Eilam D, Szechtman H (1989) Biphasic effect of D-2 agonist quinpirole on locomotion and movements. Eur J Pharmacol 161:151–157 10.1016/0014-2999(89)90837-6
[17]
Franklin K, Paxinos G (1997) The mouse brain in stereotaxic coordinates. Academic, San Diego
[18]
Garcia-Sanz A, Badia A, Clos M (2001) Differential effect of quinpirole and 7-OH-DPAT on the spontaneous [(3)H]-dopamine efflux from rat striatal synaptosomes. Synapse 40:65–73 10.1002/1098-2396(200104)40:1<65::aid-syn1027>3.0.co;2-i
[19]
Giuffrida A, Parsons L, Kerr T, Rodriguez dF, Navarro M, Piomelli D (1999) Dopamine activation of endogenous cannabinoid signaling in dorsal striatum. Nat Neurosci 2:358–363 10.1038/7268
[20]
Glass M, Felder C (1997) Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1 receptor. J of Neurosci 17:5327–5333 10.1523/jneurosci.17-14-05327.1997
[21]
Gorriti MA, Ferrer B, del Arco I, Bermudez-Silva FJ, de Diego Y, Fernandez-Espejo E, Navarro M, Rodriguez de Fonseca F (2005) Acute delta9-tetrahydrocannabinol exposure facilitates quinpirole-induced hyperlocomotion. Pharmacol Biochem Behav 81:71–77 10.1016/j.pbb.2005.02.004
[22]
Gruenberg J, Griffiths G, Howell K (1989) Characterization of the early endosome and putative endocytic carrier vesicles in vivo and with an assay of vesicle fusion in vitro. J Cell Biol 108:1301–1316 10.1083/jcb.108.4.1301
[23]
Hersch SM, Yi H, Heilman CJ, Edwards RH, Levey AI (1997) Subcellular localization and molecular topology of the dopamine transporter in the striatum and substantia nigra. J Comp Neurol 388:211–227 10.1002/(sici)1096-9861(19971117)388:2<211::aid-cne3>3.0.co;2-4
[24]
Hooks M, Kalivas P (1995) The role of mesoaccumbens--pallidal circuitry in novelty-induced behavioral activation. Neurosci 64:587–597 10.1016/0306-4522(94)00409-x
[26]
Jarrahian A, Watts VJ, Barker EL (2004) D2 dopamine receptors modulate Galpha-subunit coupling of the CB1 cannabinoid receptor. J Pharmacol Exp Ther 308:880–886 10.1124/jpet.103.057620
[27]
Kalivas PW, Duffy P (1997) Dopamine regulation of extracellular glutamate in the nucleus accumbens. Brain Res 761:173–177 10.1016/s0006-8993(97)00464-2
[28]
Kalivas P, Churchill L, Klitenick M (1993) GABA and enkephalin projection from the nucleus accumbens and ventral pallidum to the ventral tegmental area. Neurosci 57:1047–1060 10.1016/0306-4522(93)90048-k
[29]
Katona I, Rancz E, Acsady L, Ledent C, Mackie K, Hajos N, Freund T (2001) Distribution of CB1 cannabinoid receptors in the amygdala and their role in the control of GABAergic transmission. J Neurosci 21:9506–9518 10.1523/jneurosci.21-23-09506.2001
[30]
Katona I, Sperlagh B, Sik A, Kafalvi A, Vizi E, Mackie K, Freund T (1999) Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons. J Neurosci 19:4544–4558 10.1523/jneurosci.19-11-04544.1999
[31]
Kearn C, Blake-Palmer K, Daniel E, Mackie K, Glass M (2005) Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors enhances heterodimer formation: a mechanism for receptor cross-talk? Mol Pharmacol 67:1697–1704 10.1124/mol.104.006882
[32]
Kienast T, Heinz A (2006) Dopamine and the diseased brain. CNS Neurol Disord Drug Targets 5:109–131 10.2174/187152706784111560
[33]
Kim O, Ariano M, Namkung Y, Marinec P, Kim E, Han J, Sibley D (2008) D2 dopamine receptor expression and trafficking is regulated through direct interactions with ZIP. J Neurochem 106:83–95 10.1111/j.1471-4159.2008.05348.x
[34]
Kita J, Parker L, Phillips P, Garris P, Wightman R (2007) Paradoxical modulation of short-term facilitation of dopamine release by dopamine autoreceptors. J Neurochem 102:1115–1124 10.1111/j.1471-4159.2007.04621.x
[35]
Lee B, London ED, Poldrack RA, Farahi J, Nacca A, Monterosso JR, Mumford JA, Bokarius AV, Dahlbom M, Mukherjee J, Bilder RM, Brody AL, Mandelkern MA (2009) Striatal dopamine d2/d3 receptor availability is reduced in methamphetamine dependence and is linked to impulsivity. J Neurosci 29:14734–14740 10.1523/jneurosci.3765-09.2009
[36]
Leranth C, Pickel V, Heimer L, Zaborszky L (1989) Electron microscopic pre-embedding double immunostaining methods Neuroanatomical Tract-tracing Methods 2: Recent Progress. Plenum Publishing Co., New York, pp 129–172 10.1007/978-1-4757-2055-6_6
[37]
Martin AB, Fernandez-Espejo E, Ferrer B, Gorriti MA, Bilbao A, Navarro M, Rodriguez de Fonseca F, Moratalla R (2008) Expression and function of CB1 receptor in the rat striatum: localization and effects on D1 and D2 dopamine receptor-mediated motor behaviors. Neuropsychopharmacol 33:1667–1679 10.1038/sj.npp.1301558
[38]
McDonald AJ, Muller JF, Mascagni F (2002) GABAergic innervation of alpha type II calcium/calmodulin-dependent protein kinase immunoreactive pyramidal neurons in the rat basolateral amygdala. J Comp Neurol 446:199–218 10.1002/cne.10204
[39]
Meschler J, Conley T, Howlett A (2000) Cannabinoid and dopamine interaction in rodent brain: effects on locomotor activity. Pharmacol Biochem Behav 67:567–573 10.1016/s0091-3057(00)00390-7
[40]
Dopamine Receptors: From Structure to Function

CRISTINA MISSALE, S. RUSSEL NASH, SUSAN W. ROBINSON et al.

Physiological Reviews 1998 10.1152/physrev.1998.78.1.189
[41]
Mogenson G, Wu M (1991) Effects of administration of dopamine D2 agonist quinpirole on exploratory locomotion. Brain Res 551:216–220 10.1016/0006-8993(91)90935-o
[42]
Mulder J, Aguado T, Keimpema E, Barabas K, Ballester Rosado CJ, Nguyen L, Monory K, Marsicano G, Di Marzo V, Hurd YL, Guillemot F, Mackie K, Lutz B, Guzman M, Lu HC, Galve-Roperh I, Harkany T (2008) Endocannabinoid signaling controls pyramidal cell specification and long-range axon patterning. Proc Natl Acad Sci USA 105:8760–8765 10.1073/pnas.0803545105
[43]
Murer M, Dziewczapolski G, Salin P, Vila M, Tseng K, Ruberg M, Rubinstein M, Kelly M, Grandy D, Low M, Hirsch E, Raisman-Vozari R, Gershanik O (2000) The indirect basal ganglia pathway in dopamine D(2) receptor-deficient mice. Neuroscience 99:643–650 10.1016/s0306-4522(00)00223-2
[44]
Namkung Y, Dipace C, Javitch JA, Sibley DR (2009) G protein-coupled receptor kinase-mediated phosphorylation regulates post-endocytic trafficking of the D2 dopamine receptor. J Biol Chem 284:15038–15051 10.1074/jbc.m900388200
[45]
Nicola S (2007) The nucleus accumbens as part of a basal ganglia action selection circuit. Psychopharmacology (Berl) 191:521–550 10.1007/s00213-006-0510-4
[46]
Nirenberg M, Chan J, Pohorille A, Vaughan R, Uhl G, Kuhar M, Pickel V (1997) The dopamine transporter: comparative ultrastructure of dopaminergic axons in limbic and motor compartments of the nucleus accumbens. J Neurosci 17:6899–6907 10.1523/jneurosci.17-18-06899.1997
[47]
Noble E (2003) D2 dopamine receptor gene in psychiatric and neurologic disorders and its phenotypes. Am J Med Genet 116B:103–125 10.1002/ajmg.b.10005
[48]
O’Neill C, Evers-Donnelly A, Nicholson D, O’Boyle KM, O’Connor JJ (2009) D2 receptor-mediated inhibition of dopamine release in the rat striatum in vitro is modulated by CB1 receptors: studies using fast cyclic voltammetry. J Neurochem 108:545–551 10.1111/j.1471-4159.2008.05782.x
[49]
Oertel W, Mugnaini E (1984) Immunocytochemical studies of GABAergic neurons in rat basal ganglia and their relations to other neuronal systems. Neurosci Lett 47:233–238 10.1016/0304-3940(84)90519-6
[50]
Ong W, Mackie K (1999) A light and electron microscopic study of the CB1 cannabinoid receptor in the primate spinal cord. J Neurocytol 28:39–45 10.1023/a:1007011700677

Showing 50 of 77 references

Metrics
10
Citations
77
References
Details
Published
Dec 08, 2011
Vol/Issue
221(1)
Pages
101-113
Cite This Article
Diane A. Lane, June Chan, Megan L. Fitzgerald, et al. (2011). Quinpirole elicits differential in vivo changes in the pre- and postsynaptic distributions of dopamine D2 receptors in mouse striatum: relation to cannabinoid-1 (CB1) receptor targeting. Psychopharmacology, 221(1), 101-113. https://doi.org/10.1007/s00213-011-2553-4